Evidence map›Paper›PMID 41716264›Full record

ArticleFrontiers in microbiology2026

Genome and drug resistance analysis of

Jieying Wang, Chunrong Li, Xianliang Zheng, Zhuolin Chen, Wen Ye, Yuni Xu, Wenhua Qiu, Shaowen Chen, Hua Pei, Yeteng Zhong

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Frontiers in immunology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jieying Wang *Department of Clinical Laboratory, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Chunrong Li *Department of Clinical Laboratory, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Xianliang Zheng *Department of Clinical Laboratory, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Zhuolin ChenDepartment of Clinical Laboratory, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Wen YeDepartment of Clinical Laboratory, People's Hospital of Changshan, Quzhou, Zhejiang, China.
Yuni XuDepartment of Clinical Laboratory, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Wenhua QiuDepartment of Clinical Laboratory, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Shaowen ChenDepartment of Clinical Laboratory, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Hua PeiDepartment of Clinical Laboratory, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Yeteng ZhongDepartment of Clinical Laboratory, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Based on whole-genome sequencing (WGS) technology, the species distribution, genetic correlations, virulence and drug resistance gene characteristics of the clinical isolates of Methods: A total of 113 MABC strains from the Second Affiliated Hospital of Hainan Medical University from 2014 to 2023 were collected. Whole-genome sequencing (WGS) was used for subspecies identification (Average Nucleotide Identity, ANI), genetic distance analysis (single nucleotide polymorphism, SNP), and pan-genome analysis. The distribution of virulence and antibiotic resistance genes was analyzed through the Virulence Factor Database (VFDB) and the Comprehensive Antibiotic Resistance Database (CARD). The drug susceptibility phenotypes were detected by the microbroth dilution method. Results: Among the 113 MABC strains, Conclusion: In Hainan region, environmental exposure is the main source of MABC infection. Whole genome analysis suggests the potential risk of local common exposure. Mma has a better treatment prospect due to its low clindamycin resistance rate. The differentiation of virulence and resistance genes among subtypes provides a molecular basis for the precise prevention and control of MABC infection in tropical regions.

Indexed as

average nucleotide identity (ANI)drug resistanceMycobacterium abscessus complex (MABC)pan-genomevirulence gene

Identifiers

PMID41716264
PMCPMC12913411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.